SCHEMBL650146

SCHEMBL650146

CCCCn1c(-c2ccccc2)nc(Cl)c1CN(Cc1ccc(OC(C)=O)cc1)Cc1ccc2c(c1)OCCO2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.51
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
TSHR P16473 1/20 0.41
ALDH1A1 P00352 4/20 0.38
MAPK1 P28482 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
PKM P14618 1/20 0.36
GAA P10253 1/20 0.36
PSEN1 P49768 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651208 0.94 C5AR1 (0.49) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL648948 0.94 C5AR1 (0.50) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL650148 0.91 C5AR1 (0.48) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL1913084 0.91 C5AR1 (0.51) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL652376 0.90 C5AR1 (0.58) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL651031 0.90 C5AR1 (0.48) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL648636 0.90 C5AR1 (0.51) C5AR1TSHRALDH1A1MAPK1PTGDR2
SCHEMBL650147 0.90 C5AR1 (0.51) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL1912840 0.89 C5AR1 (0.63) C5AR1PPARGPPARATSHRALDH1A1
SCHEMBL648693 0.89 C5AR1 (0.55) C5AR1PPARGPPARATSHRPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed